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Homocysteine thiolactone is a product of an error-editing reaction, catalyzed by Escherrchiu colr and Saccharomyces cerevrsiae methionyl-tRNA 
synthetases, which prevents incorporation of homocysteine into tRNA and protein both in vitro and in vivo. Here, homocysteine thiolactone is 
also shown to be synthesized by cultured mammalian cells such as human cervical carcinoma (HeLa), mouse renal adenocarcinoma (RAG), and 
Chinese hamster ovary (CHO) cells labeled with [‘5S]methionine, but not by normal human and mouse (Balblc 3T3) fibroblasts. A temperature- 
sensitive methionyl-tRNA synthetase mutant of CHO cells, Met-l, does not make the thiolactone at the non-permissive temperature. The data 
indicate that methionyl-tRNA synthetase is involved in synthesis of homocysteine thiolactone in CHO cells, thereby extending this important 
proofreading mechanism to mammalian cells. 
Methionyl-tRNA synthetase: Homocysteine thiolactone; Translational accuracy; Error-editmg reaction 
1. INTRODUCTION 
Accurate reading of the genetic code is determined by 
two pivotal steps of protein synthesis. In the first step, 
each of the twenty aminoacyl-tRNA synthetases cor- 
rectly matches a cognate amino acid selected from the 
twenty protein amino acids (and a few nonprotein ones 
like homocysteine, homoserine, ornithine, etc.) with a 
cognate tRNA selected from the twenty tRNA families. 
In the second step, a correct aminoacyl-tRNA is se- 
lected in the codon programmed ribosomal A site. High 
accuracy of aminoacyl-tRNA synthetases assures 
proper assignment of an amino acid to its cognate 
tRNA and is achieved by highly specific recognition of 
tRNA [l] and by proofreading or editing mechanisms 
which remove errors in amino acid selection [2,3]. 
The editing mechanism of methionyl-tRNA synthe- 
tase is directed against homocysteine, which is an oblig- 
atory intermediate in methionine biosynthesis in all or- 
ganisms. As expected from in vitro studies [4,5], ho- 
mocysteine can be misactivated in vivo at unacceptably 
high levels [6,7]. Misactivated homocysteine is very effi- 
ciently edited, both in vitro [5] and in vivo [6,7], which 
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prevents its incorporation into cellular proteins in mi- 
croorganisms. 
A distinctive feature of homocysteine diting is that 
the enzyme-bound homocysteinyl adenylate (I) is cy- 
clized to yield homocysteine thiolactone (II) (Equation 
1): 
NH: 
I c- 4 0 \ - 0 =o + AMP AMP SH S 
I II (1) 
This allowed editing to be studied in vivo and led to 
experimental measurements of the energy costs associ- 
ated with editing of homocysteine by methionyl-tRNA 
synthetase in E. coli [6] and the yeast S. cerevisiue [7]. 
Here we report that homocysteine thiolactone is synthe- 
sized by mammalian cells in tissue culture. In Chinese 
hamster ovary (CHO) cells, the thiolactone synthesis is 
due to editing of homocysteine by methionyl-tRNA 
synthetase. thus establishing the existence of an error- 
editing mechanism in mammalian cells. 
2. MATERIALS AND METHODS 
2.1. Cell lines 
Normal human fibroblasts (GM1374) were obtained from NIGMS 
Human Genetic Mutant Cell Repository (Camden, NJ). Human cervi- 
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cal carcinoma (HeLa) was from American Type Culture Collection 
(Rockville, MD). Normal embryonic mouse fibroblasts (Balb/c 3T3 
A31) [8] and mouse renal adenocarcinoma (RAG) [9] cells were ob- 
tained from H. Ozer [IO] and R. Athwal, respectively (New Jersey 
Medical School, Newark, NJ). Temperature-sensitive Chinese ham- 
ster ovary (CHO) mutants for methionyl-tRNA (Met-l) and arginyl- 
tRNA (Arg-1) synthetases as well as parental wild type (Gat-; glycine, 
adenosine and thymidine requiring) were kindly supplied by Larry 
Thompson (Lawrence Livermore Laboratory, Livermore. CA) (11). 
2.2. Cell culture and 3sS-labeling conditions 
Cells were maintained as monolayer cultures in 10 cm dishes at 37°C 
or 34°C (CHO cells) in an atmosphere of 7.5% CO,_. The culture 
medium was a-MEM (Gibco) supplemented with 10% fetal bovine 
serum (Gibco), 10 &ml adenosine, and 10 &ml deoxythymidme. 
For “S-labeling, cells were plated in 3 cm dishes and grown to 70-80% 
confluency. The medium was then replaced with 0.45 ml methionine- 
free a-MEM supplemented with 5% fetal bovine serum, 10 pg/ml 
adenosine. 10 pg/ml deoxythymidine, and 10 PM [“SJmethionine at 
0.1 mCi/ml (lo4 Ci/mol; 1 Ci = 37 GBq) (Amersham). Unless other- 
wise stated, cells were labeled at 37’C for 6 h. 
2.3. Preparation und analysis of “S-labeled extracts 
At specified time intervals, cell-free medium was removed and fro- 
zen at -80°C. Cells were extracted with 2 x 0.125 ml 1 M formic acid 
at 0°C for 30 min and frozen at -80°C. Incorporation of [?S]methion- 
ine into protein was determined by trichloroacetic acid precipitation. 
Levels of homocysteine thiolactone in samples were determined by 
two-dimensional TLC. Prior to TLC, samples were thawed and clari- 
fied by centrifugation in an Eppendorf microcentrifuge for 5 min at 
4°C. Two-dimensional TLC was carried out as described previously 
[7]. Radioactivity co-migrating on TLC plates with an authentic ho- 
mocysteine thiolactone (Sigma) standard was visualized by autoradi- 
ography and quantitated by scintillation counting. In control experi- 
ments, the radioactivity associated with homocysteme thiolactone 
spots was shown to be sensitive to NaOH treatment. The method 
allows detection of homocysteine thiolactone at concentrations as low 
as 1 nM. Commercial preparations of [‘5S]methionine were found to 
contam < 0.01% [“Slhomocysteine thiolactone. 
3. RESULTS 
Labeling protocols utilizing 35S-labeled sulfate or cys- 
teine which allowed detection of homocysteine thiolac- 
tone in microorganisms [6,7] cannot be used with mam- 
malian cells due to different organization of relevant 
metabolic pathways [12]. In mammalian cells. the 
transsulfuration pathway converts methionine, an es- 
sential amino acid, into cysteine with homocysteine as 
an intermediate (Fig. 1). The pathway starts with for- 
mation of S-adenosylmethionine, which yields S-adeno- 
sylhomocysteine in subsequent ransmethylation reac- 
tions. In addition to being transformed into cysteine, 
homocysteine is remethylated back to methionine. 
Thus, the conversion of methionine to homocysteine 
can be exploited in order to determine whether ho- 
mocysteine thiolactone is formed in mammalian cells. 
Several different mammalian cell lines growing in 
monolayer cultures were labeled with [35S]methionine 
for 6 h. Aliquots of cell-free media as well as formic acid 
extracts of labeled cells were analyzed by two-dimen- 
sional TLC and the thiolactone spots were quantitated 
by scintillation counting. As shown in Table I, ho- 
mocysteine thiolactone was present in cultures of HeLa 
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Fig. 1. Schematic representation of metabolism of homocysteine and 
methionine in mammalian cells [12]. Syntheses of homocysteine thi- 
olactone by mammalian cells has been established in this work. 
cells, mouse RAG cells, and CHO cells. Most (95%) of 
the thiolactone formed in cell cultures was found in 
cell-free media, which indicates that the thiolactone is 
secreted from cells, as found previously with microbial 
cells [6,7]. The highest level of homocysteine thiolactone 
of 17.4 pmol/lO’ cells, measured in RAG cell cultures, 
corresponds to a homocysteine thiolactone concentra- 
tion of 20 nM in cell-free medium. Homocysteine thi- 
olactone was not detectable in cell cultures of normal 
human (GM1374) and mouse (Balb/c 3T3) fibroblasts 
at any time of labeling up to 24 h (Table I). Control 
experiments showed that these cells incorporated 
[3SS]methionine into S-adenosylmethionine and protein 
as expected (not shown). 
By normalizing the amount of homocysteine thiolac- 
tone to incorporation of methionine into protein, one 
can estimate the fraction of methionine metabolized 
into the thiolactone in mammalian cells. The highest 
fraction (0.6%) of methionine was converted into ho- 
mocysteine thiolactone in mouse RAG cells. This level 
Table I 
Homocysteine thiolactone levels and ratios of homocysteine thiolac- 
tone to incorporation of methionine into protein m mammalian tissue 
cultures 
Cell line 
Human 
Normal fibroblasts 
(GM1374) 
HeLa 
Mouse 
Balb/c 3T3 (A3lN) 
RAG 
Chmese hamster ovary 
(Gat ) 
Hey thiolactone Hey thiolactone/ 
(pmol/lO’ cells) protein x lo5 
< 0.06” <2 
0.9 16 
< 0.2” < 10 
17.4 600 
2.0 240 
The thiolactone levels were measured at 37°C (human and mouse 
cells) or 34°C (CHO cells) as described in section 2. 
Similar results were obtained after 3, 6, 12 and 24 h labeling. 
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of the thiolactone synthesis is comparable to that ob- 
served in microbial cells [6,7]. 
In order to test whether methionyl-tRNA synthetase 
is involved in synthesis of homocysteine thio-lactone, 
the thiolactone levels were measured in Met-l, a 
methionyl-tRNA synthetase mutant of CHO cells. The 
Met-l mutant has a temperature-sensitive methionyl- 
tRNA synthetase and grows at 34°C but not at 39.5”C. 
Methionyl-tRNA synthetase activity is undetectable in 
crude extracts prepared from the Met-l mutant cells at 
any temperature [l 11, which we have also confirmed. As 
shown in Table II, the Met-l mutant produces less ho- 
mocysteine thiolactone than wild type even at the per- 
missive temperature (34°C). At a nonpermissive tem- 
perature (39.5”Q no thiolactone was detectable in cul- 
tures of the Met-l mutant whereas wild type cells made 
10 times more thiolactone at this temperature than at 
34°C. In order to rule out the possibility of effects due 
to aminoacyl-tRNA synthetase mutations in general, or 
other non-specific effects, a control experiment was per- 
formed with a temperature-sensitive arginyl-tRNA syn- 
thetase mutant, Arg-1. This control experiment showed 
that the Arg-I mutation did not diminish homocysteine 
thiolactone levels at 39.5”C and, for reasons not under- 
stood, actually had a 3- to 4-fold increase in the thiolac- 
tone levels at 34’C. It is not clear why homocysteine 
thiolactone levels increase at 39.5”C in wild type and 
Arg-1 cells. Perhaps relative affinity of homocysteine 
for methionyl-tRNA synthetase is greater at 39.5”C 
than at 34°C. More important, however, is the fact that 
the Met-l mutant was partially deficient in homocys- 
teine thiolactone synthesis at a permissive temperature 
and totally deficient at a nonpermissive temperature, 
which indicates that methionyl-tRNA synthetase is in- 
volved in homocysteine thiolactone synthesis in CHO 
cells. 
Table II 
Homocysteine thiolactone levels in cultures of wild type and tempera- 
ture-sensitive aminoacyl-tRNA synthetase mutants of Chinese ham- 
ster ovary cells 
Cell line Homocysteine thiolactone 
(pmol/lO’ cells) 
34°C 395°C 
Wild type, 6 h 2.0 3.7 
12 h 1.6 16.4 
Met-l, 6 h 0.3 < 0.1 
12 h 0.5 < 0.1 
Arg-1, 6 h 3.0 5.8 
12 h 1.6 21.3 
The thiolactone levels were measured at 34°C and 395°C after 6 h and 
12 h of labeling with [“Slmethionine as described in section 2. 
4. DISCUSSION 
The presence of homocysteine thiolactone in mam- 
malian cell cultures and involvement of methionyl- 
tRNA synthetase in its synthesis document conserva- 
tion of a basic error editing mechanism in selection of 
amino acids for protein synthesis in cells of organisms 
as diverse as bacteria and mammals. This editing reac- 
tion (Eq. 1) was discovered in vitro [5] and subsequently 
shown to exist in vivo in E. coli and S. cerevisiue (6,7). 
It is possible that homocysteine thiolactone can be made 
from methionine by another route in mammalian cells; 
however, the behavior of the Met-l mutant of CHO 
cells indicated that the thiolactone is synthesized by 
methionyl-tRNA synthetase (Table II), and it seems 
unlikely that methionyl-tRNA synthetase would con- 
vert methionine into homocysteine thiolactone. Moreo- 
ver, homocysteine thiolactone levels are positively cor- 
related with Hey/Met ratios: cells known to have higher 
Hey/Met ratios (e.g. a variety of transformed cells; refs. 
[ 13,141) also produce more homocysteine thiolactone 
(Table I). Thus, the mechanism of homocysteine thi- 
olactone formation from methionine in mammalian 
cells most likely involves the route depicted in Fig. 1. 
Similar mechanism has also been shown to be responsi- 
ble for homocysteine thiolactone formation from 
methionine in bacterial cells [15]. 
Homocysteine thiolactone has not previously been 
reported in cultured mammalian cells. However, there 
were several attempts to detect homocysteine thiolac- 
tone in mammalian tissues. Spindel and McCully [16] 
reported that intraperitoneally injected [i4C]methionine 
was metabolized into [‘4C]homocysteine thiolactone in 
guinea pig liver, but the identification of the 14C-radio- 
activity was questionable because the aqueous wash 
procedure, which removes authentic homocysteine thi- 
olactone from chloroform-methanol extracts, failed to 
remove the “C-radioactivity from chloroform/metha- 
nol extracts of the liver. Homocysteine thiolactone has 
been reported to be absent in human serum and plasma 
[17-191 and in rabbit plasma and urine [20] but the 
detection limits (10-50 PM) of the methods used were 
poor. In this study, using a method allowing detection 
of homocysteine thiolactone at nanomolar concentra- 
tions, we have demonstrated that the thiolactone is a 
component of sulfur amino acid pools in mammalian 
cells in tissue culture. The levels of homocysteine thi- 
olactone in tissue cultures of at least some mammalian 
cells can be as high as the thiolactone levels in cultures 
of microbial cells. 
Our inability to detect the thiolactone in normal 
mammalian cells is reminiscent of the situation in wild 
type yeast cells in which homocysteine thiolactone is 
almost undetectable [7]. Apparently, in normal mam- 
malian cells, as in yeast, the need for homocysteine 
editing is minimized due to the presence of a pathway 
that converts homocysteine into cysteine (Fig. 1) which 
239 
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leads to relatively low Hey/Met ratios. The Hey/Met 
ratios for normal diploid cells are 0.06 [13], a value 
similar to that in wild type yeast cells [7]. In transformed 
human diploid cells the Hey/Met ratio is 0.15 [ 131. 
The observation that homocysteine thiolactone is 
present in transformed mammalian cells but undetecta- 
ble in normal cells is consistent with the notion that 
transformation leads to imbalances in metabolism of 
homocysteine and methionine [13,14,21] and raises a 
possibility that the thiolactone may be a biochemical 
marker for transformed cells. It should be noted that 
methionyl-tRNA synthetase levels are similar in normal 
and transformed human fibroblasts [22], which indi- 
cates that increased homocysteine thiolactone synthesis 
in transformed cells is not due to increases in methionyl- 
tRNA synthetase levels. Altered metabolism of ho- 
mocysteine and methionine in transformed cells is man- 
ifested phenotypically as an inability of the transformed 
cells to grow in methionine-free homocysteine medium 
[13,14,20,23]. The enhanced ability of transformed cells 
to synthesize homocysteine thiolactone described here 
may also contribute to this phenotype. Transformed 
cells incubated in homocysteine medium have Hey/Met 
ratios at least 20 times higher than normal cells [13,14]. 
Such high Hey/Met ratios would lead to excessive syn- 
thesis of homocysteine thiolactone by methionyl-tRNA 
synthetase which is inadvertently associated with expen- 
diture of energy (ATP hydrolysis) and may be reflected 
in slower growth rate [7]. As shown in Table I, 0.6% of 
energy used for synthesis of Met-tRNA is expended on 
homocysteine editing in RAG cells. In homocysteine 
medium the energy expenditure would increase to over 
12%. This level of the energy expended on editing is 
known to diminish growth rate in yeast [7]. 
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